Confluence Wealth Services, Inc. Amgen Inc Transaction History

Confluence Wealth Services, Inc.

$1.31 Billion
Q3 2024

A detailed history of Confluence Wealth Services, Inc. transactions in Amgen Inc stock. As of the latest transaction made, Confluence Wealth Services, Inc. holds 2,432 shares of AMGN stock, worth $680,984. This represents 0.06% of its overall portfolio holdings.

Number of Shares

2,432

Previous 2,413 0.79%

Holding current value

$680,984

Previous $753,000 3.98%

% of portfolio

0.06%

Previous 0.06%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 29, 2024	BUY	$309.38 - $337.38 $5,878 - $6,410	19 Added 0.79%	2,432 $783,000
Q2 2024 Jul 31, 2024	BUY	$262.75 - $319.31 $289,287 - $351,560	1,101 Added 83.92%	2,413 $753,000
Q1 2024 Apr 22, 2024	SELL	$268.87 - $324.56 $65,873 - $79,517	-245 Reduced 15.74%	1,312 $373,000
Q4 2023 Jan 25, 2024	BUY	$255.7 - $288.46 $7,671 - $8,653	30 Added 1.96%	1,557 $448,000
Q3 2023 Nov 01, 2023	SELL	$218.65 - $271.46 $33,890 - $42,076	-155 Reduced 9.22%	1,527 $410,000
Q2 2023 Aug 01, 2023	SELL	$214.27 - $253.37 $28,926 - $34,204	-135 Reduced 7.43%	1,682 $373,000
Q1 2023 May 11, 2023	BUY	$225.79 - $275.2 $25,288 - $30,822	112 Added 6.57%	1,817 $439,000
Q4 2022 Feb 10, 2023	SELL	$229.03 - $291.01 $916 - $1,164	-4 Reduced 0.23%	1,705 $447,000
Q3 2022 Nov 08, 2022	SELL	$224.46 - $253.15 $525,685 - $592,877	-2,342 Reduced 57.81%	1,709 $385,000
Q2 2022 Aug 15, 2022	BUY	$230.71 - $256.74 $36,452 - $40,564	158 Added 4.06%	4,051 $1.01 Million
Q1 2022 Apr 26, 2022	BUY	$219.27 - $242.57 $4,385 - $4,851	20 Added 0.52%	3,893 $941,000
Q4 2021 Feb 10, 2022	BUY	$198.88 - $227.6 $770,262 - $881,494	3,873 New	3,873 $871,000

Others Institutions Holding AMGN

# of Institutions

3,123

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $150B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Confluence Wealth Services, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Confluence Wealth Services, Inc. with notifications on news.

Account

Confluence Wealth Services, Inc. Amgen Inc Transaction History